SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$4.45 USD
-0.04 (-0.89%)
Updated Aug 2, 2024 03:59 PM ET
After-Market: $4.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for SOPHiA GENETICS SA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 62 | 48 | 40 | 28 | 25 |
Cost Of Goods | 19 | 16 | 15 | 11 | 8 |
Gross Profit | 43 | 31 | 25 | 18 | 18 |
Selling & Adminstrative & Depr. & Amort Expenses | 118 | 119 | 97 | 55 | 50 |
Income After Depreciation & Amortization | -75 | -88 | -71 | -37 | -32 |
Non-Operating Income | -4 | 0 | -2 | -4 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -79 | -88 | -74 | -41 | -34 |
Income Taxes | 0 | 0 | 0 | -2 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -79 | -87 | -74 | -39 | -34 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -79 | -87 | -74 | -39 | -34 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -66 | -82 | -68 | -35 | -30 |
Depreciation & Amortization (Cash Flow) | 8 | 6 | 4 | 2 | 2 |
Income After Depreciation & Amortization | -75 | -88 | -71 | -37 | -32 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 64.74 | 64.10 | 55.39 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.22 | -1.36 | -1.33 | NA | NA |
Diluted Net EPS (GAAP) | -1.22 | -1.36 | -1.33 | -0.93 | NA |
Fiscal Year end for SOPHiA GENETICS SA falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 15.78 | 17.05 | 16.30 | 15.05 |
Cost Of Goods | NA | 5.37 | 5.15 | 5.03 | 5.01 |
Gross Profit | NA | 10.41 | 11.90 | 11.27 | 10.05 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 29.16 | 30.85 | 27.81 | 30.09 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -18.75 | -18.95 | -16.54 | -20.04 |
Non-Operating Income | NA | 5.37 | -5.11 | 3.02 | -1.28 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -13.39 | -24.05 | -13.53 | -21.32 |
Income Taxes | NA | 0.32 | 0.01 | 0.30 | 0.07 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -13.70 | -24.06 | -13.82 | -21.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -13.70 | -24.06 | -13.82 | -21.40 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 65.26 | 65.03 | 65.83 | 64.84 |
Diluted EPS Before Non-Recurring Items | NA | -0.21 | -0.37 | -0.21 | -0.33 |
Diluted Net EPS (GAAP) | NA | -0.21 | -0.37 | -0.21 | -0.33 |